Advertisements



High Growth Non-Invasive Cancer Test Technology: Guardant Health Vs. Exact Sciences

High Growth Non-Invasive Cancer Test Technology: Guardant Health Vs. Exact Sciences.....»»

Category: topSource: seekingalphaDec 2nd, 2019

Exact Sciences (EXAS) to Post Q1 Earnings: What"s in Store?

During Exact Sciences' (EXAS) first-quarter 2019 conference call, investor focus will be on the growth rate in the company's non-invasive screening test volume for c.....»»

Category: dealsSource: nytApr 22nd, 2019

Exact Sciences Inks Cologuard Co-Promotion Deal With Pfizer

Exact Sciences (EXAS) reaches a co-promotion agreement with Pfizer to commercialize its non-invasive screening test for colorectal cancer, Cologuard. The stock rallies fo.....»»

Category: personnelSource: nytAug 23rd, 2018

Exact Sciences A "Must-Own" Growth Stock, Goldman Sachs Says In Upgrade

Shares of EXACT Sciences Corporation (NASDAQ: EXAS), which markets the non-invasive colon cancer screener Cologuard, enjoy¬†a premium valuation and hold further upside potential, according to Goldman Sach.....»»

Category: blogSource: benzingaFeb 26th, 2019

Why This Colorectal Cancer Treatment Approval Is a Big Hit

One analyst sees FDA approval of its noninvasive colorectal cancer screening test tacking on another 30% to Exact Sciences stock......»»

Category: blogSource: 247wallstSep 24th, 2019

Wall Street eases from record highs as tech drags; Fed meeting eyed

U.S. stocks retreated from record highs on Monday, weighed by technology shares ahead of high profile earnings including that of Apple, which will test the impact of trade tensions on global growth, ahead of the Federal Reserve's policy-setting meeting......»»

Category: topSource: reutersJul 29th, 2019

Diagnostic company Exact Sciences to buy Genomic Health in $2.8 billion deal

Exact Sciences Corp said on Monday it will buy peer Genomic Health Inc for about $2.8 billion in cash and stock, expanding the cancer diagnostic company's testing capabilities to breast and prostate cancers......»»

Category: topSource: reutersJul 29th, 2019

Exact Sciences to buy Genomic Health for $2.8 billion

Cancer diagnostics company Exact Sciences Corp said on Monday it will buy healthcare company Genomic Health Inc for about $2.8 billion to bolster its cancer testing business......»»

Category: topSource: reutersJul 29th, 2019

Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg

Cancer diagnostics company Exact Sciences Corp is in advanced negotiations to buy healthcare company Genomic Health Inc for about $2.8 billion to strengthen its cancer testing, Bloomberg reported on Saturday......»»

Category: topSource: reutersJul 27th, 2019

Is Exact Sciences Corp. Still a Buy in 2018?

Shareholders in the innovative colon cancer test specialist have enjoyed huge gains over the last few years......»»

Category: topSource: foxnewsApr 8th, 2018

Exact Sciences shares surge 11% on earlier cancer screening recommendation

Exact Sciences Corp. , maker of a colon cancer test, had shares surge 11% in extre.....»»

Category: topSource: marketwatchMay 30th, 2018

Exact Sciences update on liver cancer test a positive, says Canaccord

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 6th, 2018

Exact Sciences" stock drops sharply as Madison company misses analysts" projections

Exact Sciences Corp., the maker of the Cologuard stool DNA-based colorectal cancer take-home test, saw a 78 percent increase in revenue for its recent second quarter when compared with the year-ago quarter, but still missed analysts' revenue projections......»»

Category: topSource: bizjournalsAug 2nd, 2018

Exact Sciences shares jump 11% premarket on news of Pfizer collaboration on Cologuard

Exact Sciences Corp. shares soared about 11% in premarket trade Wednesday, after the company said it will collaborate with Pfizer Inc. in co-promoting Cologuard, the first and only FDA-approved non-invasive stool DNA screening test fo.....»»

Category: topSource: marketwatchAug 22nd, 2018

Pfizer will promote Mayo-developed colon cancer test Cologuard

Global pharmaceutical company Pfizer Inc. has entered into a four-year agreement with Exact Sciences Corp. to co-promote and sell Cologuard, the noninvasive stool DNA-based colorectal cancer take-home test that was developed by Rochester, Minn.-bas.....»»

Category: topSource: bizjournalsAug 23rd, 2018

High-end FPGA demand mounting for datacenter, 5G, AIoT applications

High-end FPGA chips demand is mounting significantly for datacenter, 5G and AIoT applications, providing growth momentum for related wafer foundry, analysis and test players as well as channel distributors, according to industry sources......»»

Category: topSource: digitimesNov 19th, 2019

Guardant Health best-in-class growth play, says Canaccord

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 8th, 2019

Exact Sciences" carcinoma detection test granted FDA breathrough designation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 8th, 2019

Exact Sciences completes combination with Genomic Health

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 8th, 2019

Genomic Health stockholders approve proposed acquisition by Exact Sciences

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 7th, 2019

Guardant Health initiates ECLIPSE study for LUNAR-2 blood test

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 23rd, 2019